Literature DB >> 31118153

Deprescribing in Older Adults With Cardiovascular Disease.

Ashok Krishnaswami1, Michael A Steinman2, Parag Goyal3, Andrew R Zullo4, Timothy S Anderson5, Kim K Birtcher6, Sarah J Goodlin7, Mathew S Maurer8, Karen P Alexander9, Michael W Rich10, Jennifer Tjia11.   

Abstract

Deprescribing, an integral component of a continuum of good prescribing practices, is the process of medication withdrawal or dose reduction to correct or prevent medication-related complications, improve outcomes, and reduce costs. Deprescribing is particularly applicable to the commonly encountered multimorbid older adult with cardiovascular disease and concomitant geriatric conditions such as polypharmacy, frailty, and cognitive dysfunction-a combination rarely addressed in current clinical practice guidelines. Triggers to deprescribe include present or expected adverse drug reactions, unnecessary polypharmacy, and the need to align medications with goals of care when life expectancy is reduced. Using a framework to deprescribe, this review addresses the rationale, evidence, and strategies for deprescribing cardiovascular and some noncardiovascular medications.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  deprescribing; geriatrics; medications; multimorbidity; multiple chronic conditions; older adults; polypharmacy

Year:  2019        PMID: 31118153      PMCID: PMC6724706          DOI: 10.1016/j.jacc.2019.03.467

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  48 in total

1.  Are nonspecific practice guidelines potentially harmful? A randomized comparison of the effect of nonspecific versus specific guidelines on physician decision making.

Authors:  P G Shekelle; R L Kravitz; J Beart; M Marger; M Wang; M Lee
Journal:  Health Serv Res       Date:  2000-03       Impact factor: 3.402

2.  Polypharmacy, adverse drug reactions, and geriatric syndromes.

Authors:  Bhavik M Shah; Emily R Hajjar
Journal:  Clin Geriatr Med       Date:  2012-05       Impact factor: 3.076

3.  Reconsidering medication appropriateness for patients late in life.

Authors:  Holly M Holmes; Déon Cox Hayley; G Caleb Alexander; Greg A Sachs
Journal:  Arch Intern Med       Date:  2006-03-27

4.  We need minimally disruptive medicine.

Authors:  Carl May; Victor M Montori; Frances S Mair
Journal:  BMJ       Date:  2009-08-11

5.  Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance.

Authors:  Cynthia M Boyd; Jonathan Darer; Chad Boult; Linda P Fried; Lisa Boult; Albert W Wu
Journal:  JAMA       Date:  2005-08-10       Impact factor: 56.272

6.  Ethical framework for medication discontinuation in nursing home residents with limited life expectancy.

Authors:  Jennifer Tjia; Jane Givens
Journal:  Clin Geriatr Med       Date:  2012-02-23       Impact factor: 3.076

7.  Factors leading to excessive polypharmacy.

Authors:  Bo Hovstadius; Göran Petersson
Journal:  Clin Geriatr Med       Date:  2012-02-15       Impact factor: 3.076

8.  The implications of therapeutic complexity on adherence to cardiovascular medications.

Authors:  Niteesh K Choudhry; Michael A Fischer; Jerry Avorn; Joshua N Liberman; Sebastian Schneeweiss; Juliana Pakes; Troyen A Brennan; William H Shrank
Journal:  Arch Intern Med       Date:  2011-05-09

9.  Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process.

Authors:  Kevin T Bain; Holly M Holmes; Mark H Beers; Vittorio Maio; Steven M Handler; Stephen G Pauker
Journal:  J Am Geriatr Soc       Date:  2008-09-02       Impact factor: 5.562

10.  Competing risk and heterogeneity of treatment effect in clinical trials.

Authors:  David M Kent; Alawi Alsheikh-Ali; Rodney A Hayward
Journal:  Trials       Date:  2008-05-22       Impact factor: 2.279

View more
  34 in total

Review 1.  Hypertension Management in Nursing Homes: Review of Evidence and Considerations for Care.

Authors:  Michelle Vu; Loren J Schleiden; Michelle L Harlan; Carolyn T Thorpe
Journal:  Curr Hypertens Rep       Date:  2020-01-14       Impact factor: 5.369

2.  Patient-Reported Barriers and Facilitators to Deprescribing Cardiovascular Medications.

Authors:  Parag Goyal; Tatiana Requijo; Birgit Siceloff; Megan J Shen; Ruth Masterson Creber; Sarah N Hilmer; Ian M Kronish; Mark S Lachs; Monika M Safford
Journal:  Drugs Aging       Date:  2020-02       Impact factor: 3.923

3.  Nursing Home Residents' Thoughts on Discussing Deprescribing of Preventive Medications.

Authors:  Wade Thompson; Ida Theemann Jacobsen; Dorte Ejg Jarbøl; Peter Haastrup; Jesper Bo Nielsen; Carina Lundby
Journal:  Drugs Aging       Date:  2020-03       Impact factor: 3.923

4.  Attitudes toward deprescribing for hospital inpatients.

Authors:  Richard Gilpin; Olwen C McDade; Chris Edwards
Journal:  Clin Med (Lond)       Date:  2022-01       Impact factor: 2.659

5.  Predictors of Hip Fracture Despite Treatment with Bisphosphonates among Frail Older Adults.

Authors:  Andrew R Zullo; Mark N Sorial; Yoojin Lee; Christine W Lary; Douglas P Kiel; Sarah D Berry
Journal:  J Am Geriatr Soc       Date:  2019-10-03       Impact factor: 5.562

6.  Physician Perspectives on Deprescribing Cardiovascular Medications for Older Adults.

Authors:  Parag Goyal; Timothy S Anderson; Gwen M Bernacki; Zachary A Marcum; Ariela R Orkaby; Dae Kim; Andrew Zullo; Ashok Krishnaswami; Arlene Weissman; Michael A Steinman; Michael W Rich
Journal:  J Am Geriatr Soc       Date:  2019-09-11       Impact factor: 5.562

7.  Perspectives on Implementing a Multidomain Approach to Caring for Older Adults With Heart Failure.

Authors:  Parag Goyal; Eiran Z Gorodeski; Kelsey M Flint; Deena S Goldwater; John A Dodson; Jonathan Afilalo; Mathew S Maurer; Michael W Rich; Karen P Alexander; Scott L Hummel
Journal:  J Am Geriatr Soc       Date:  2019-10-18       Impact factor: 5.562

8.  Comparative Effectiveness of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in Older Nursing Home Residents After Myocardial Infarction: A Retrospective Cohort Study.

Authors:  Andrew R Zullo; Melissa R Riester; Sebhat Erqou; Wen-Chih Wu; James L Rudolph; Michael A Steinman
Journal:  Drugs Aging       Date:  2020-10       Impact factor: 3.923

9.  Care coordination needs for deprescribing benzodiazepines and benzodiazepine receptor agonists.

Authors:  Michaela McCarthy; Selene Mak; Christopher N Kaufmann; Hillary D Lum; Constance H Fung
Journal:  Res Social Adm Pharm       Date:  2021-07-01

10.  The health impacts of preventive cardiovascular medication reduction on older populations: protocol for a systematic review and meta-analysis.

Authors:  Rik S van der Veen; Joseph J Lee; Richard J McManus; Richard F D Hobbs; Kamal R Mahtani; Constantinos Koshiaris; James P Sheppard
Journal:  Syst Rev       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.